|
2024
|
Invention
|
Antisense oligonucleotide targeting atn1 mrna or pre-mrna.
The present invention provides an ant... |
|
|
Invention
|
Immobilizing method for carbon dioxide, carbon dioxide-immobilized cement hardened body, and prod... |
|
|
Invention
|
Anti-gap 43 antibody, method for producing same, and tissue analysis method and kit for tissue an... |
|
|
Invention
|
Hydraulic composition, cured body, and method for producing hydraulic composition. 2233 is 0.5 to... |
|
2023
|
Invention
|
Suppression of renal disorder induced by cyclodextrin. The present invention addresses one proble... |
|
|
Invention
|
Inorganic pigment. 1-xx741717 (In formula (1), the following relationship is satisfied: 0 < x ≤ 0... |
|
|
Invention
|
Nervous system delivery enhancer. The present invention addresses the problem of providing a new ... |
|
|
Invention
|
Agent for eliminating senescent cells.
The present invention provides an agent or pharmaceutical... |
|
|
Invention
|
Analysis method and analysis device. This analysis method comprises: performing molecular dynamic... |
|
|
Invention
|
Brazing device and method for brazing assembly. This brazing device (100) comprises: a stage (10)... |
|
|
Invention
|
Tdp-43 aggregation suppressing agent and pharmaceutical composition. Provided is a TDP-43 aggrega... |
|
|
Invention
|
Urine analysis method for chronic kidney disease. Provided is a method for testing for chronic ki... |
|
2022
|
Invention
|
Antisense oligonucleotide targeting atn1 mrna or pre-mrna. The present invention provides an anti... |
|
|
Invention
|
Method for producing hydrogen and/or carbon monoxide, method for producing synthesis gas, and rea... |
|
|
Invention
|
Drug for treating fatty liver and nonalcoholic steatohepatitis.
The present inventors have disco... |
|
|
Invention
|
Drug for treating fatty liver and non-alcoholic steatohepatitis. The inventors found that a pepti... |
|
|
Invention
|
Method, analysis system, analyzer, and computer program for analyzing cause of prolonging coagula... |
|
|
Invention
|
Regenerative agent for bone tissue and lung tissue, and pharmaceutical composition for regenerati... |
|
|
Invention
|
Machine learning device, machine learning method, sugar chain structure narrowing-down device, an... |
|
|
Invention
|
Server, api, and computer program. Provided are a server which can acquire an output of a narrowe... |
|
|
Invention
|
System, program, and method for determining hypermutated tumor. A method, a program, and a method... |
|
|
Invention
|
Magnetic field generating device.
A magnetic field generating device 1 comprises: an iron core 2... |
|
|
Invention
|
Magnetic field generating device. A magnetic field generating device 1 comprises a core 2, a pair... |
|
|
Invention
|
Method for evaluating future risk of developing dementia. The present invention addresses the pro... |
|
|
Invention
|
Cell preparation production method and hypoxic stimulation container employed therefor. Provided ... |
|
|
Invention
|
Agent for inhibiting renal damage induced by rhabdomyolysis.
One object of the present invention... |
|
|
Invention
|
Prevention of kidney injury induced by hemolytic reaction.
One object of the present invention i... |
|
|
Invention
|
Prevention of kidney injury induced by hemolytic reaction. One of the problems of the present inv... |
|
|
Invention
|
Agent for inhibiting renal damage induced by rhabdomyolysis. One of the problems addressed by the... |
|
|
Invention
|
Marker for assisting in diagnosis of nephrotic syndrome and use thereof.
The present invention p... |
|
|
Invention
|
Marker for assisting in diagnosis of nephrotic syndrome and use thereof. Provided is a use of eph... |
|
2021
|
Invention
|
Antisense nucleic acid and use thereof.
An antisense nucleic acid targeting intron 6 of TDP-43 m... |
|
|
Invention
|
Antisense nucleic acid and use thereof. This antisense nucleic acid is for a target sequence at p... |
|
|
Invention
|
Method for determining presence/absence of norovirus infection risk.
The present invention provi... |
|
|
Invention
|
Software providing apparatus, software providing method, and program.
A software providing appar... |
|
|
Invention
|
Software providing device, software providing method, and program. The present invention provides... |
|
|
Invention
|
Method for determining presence/absence of norovirus infection risk. The present invention provid... |
|
|
Invention
|
Drug for treating fatty liver and nonalcoholic steatohepatitis. The present inventors have discov... |
|
|
Invention
|
Therapeutic drug for fatty liver and nonalcoholic steatohepatitis. The inventors of the present i... |
|
|
Invention
|
Utilization of vitamin b12 in inhibiting renal disorder.
One object of the present invention is ... |
|
|
Invention
|
Utilization of vitamin b12 in inhibiting renal disorder. 1212 or a pharmaceutically acceptable sa... |
|
|
Invention
|
Method for evaluating mild cognitive impairment, calculation method, evaluation device, calculati... |
|
|
Invention
|
Pharmaceutical composition for preventing or treating cerebral small vessel disease. This pharmac... |
|
|
Invention
|
Information processing device, information processing method, and program. Provided is an informa... |
|
|
Invention
|
Data generation apparatus, data generation method, and program.
There is provided a data generat... |
|
|
Invention
|
Data generation device, data generation method, and program. Provided is a data generation device... |
|
|
Invention
|
Method for evaluating expression and function of megalin in human living tissue. The present inve... |
|
2020
|
Invention
|
Powdered fat/oil composition for promoting swallowing, and method for producing same. Provided is... |
|
|
Invention
|
Induction method for macrophage, anti-inflammatory macrophage-inducing agent, and pharmaceutical ... |
